The AMA’s new president on how abortion restrictions, AI, burnout impact physicians
Newly-elected Jesse Ehrenfeld is taking the reins at the American Medical Association at a time of pressing changes for doctors.
Hospital operating margins positive for third consecutive month: Kaufman Hall
Hospitals’ financial health has yet to return to pre-pandemic levels, but it appears to be stabilizing as Congress debates changing federal payments to providers.
HHS finalizes info blocking penalties for IT vendors, kickstarting enforcement
Having a stick in place to enforce compliance three years after the original rule is expected to more firmly move the needle on interoperability in U.S. healthcare.
State legislatures around US grapple with how to handle nursing shortages
At least eighteen states have introduced or advanced safe staffing bills this year in an effort to reduce nurse burnout and improve the quality of patient care, but hospital groups are resisting the changes.
AHA ramps up criticism of site-neutral legislation
Site-neutral payments ignore key differences between hospital outpatient departments and physician offices, the hospital lobby argued this week in a new report and briefing on Capitol Hill.
Walgreens stock plummets after pharmacy chain cuts 2023 outlook
“Our performance in the third quarter did not meet our overall expectations,” Walgreens CEO Roz Brewer told investors Tuesday morning.
Masimo shareholders elect activist investor’s two board candidates
The vote approving Politan Capital’s nominees is “a clear mandate from shareholders that significant change is needed at Masimo,” said newly elected director Quentin Koffey.
Johns Hopkins, Emeritus launch program to train healthcare leaders
Although industry analysts have focused on staffing shortages following the coronavirus pandemic, the program aims to address a gap in business skills for healthcare executives.
Pfizer, citing safety concerns, scraps one of two obesity pill hopefuls
Liver enzyme elevations in early- and mid-stage testing have led the drugmaker to discontinue development of a medicine known as lotiglipron, dealing a blow to its hopes of catching rivals Lilly and Novo Nordisk.
UnitedHealth acquires Amedisys for $3.3B after home health provider reneges on Option deal
The deal is likely to face antitrust scrutiny despite minimal geographic overlap between Amedisys and existing UnitedHealth home health business LHC Group, analysts said.